OneMedNet Corporation (Nasdaq: ONMD) announced a significant expansion of its proprietary iRWD™ network and platform, marking a greater than 25% growth that substantially enhances the company's capacity to deliver real-world data insights to pharmaceutical and healthcare organizations. The expansion includes the addition of over 5 billion administrative records that support aggregated health economics research and insights into social determinants of health.
Network Scale and Capabilities
The expanded iRWD™ network now provides customers with access to a dramatically scaled, de-identified data network comprising 1,750+ healthcare system and provider partner sites, covering 34 million patients and 136 million clinical exams. This growth represents a strategic response to rising demand for high-quality longitudinal data, rare disease insights, and datasets that include health economics and social determinants of health.
The expansion specifically addresses the growing need for inclusive data representing underserved and underrepresented populations, enabling insights across rare diseases, underserved populations, and high-demand real-world data sectors.
Strategic Market Positioning
According to Aaron Green, President & CEO of OneMedNet, "Real-World Evidence is only as powerful as the clinical integrity of the data behind it. The OneMedNet iRWD™ network and platform delivers regulatory-grade depth and precision, enabling life sciences, payers, and healthcare innovators to generate clinically grounded insights that are actionable and reflective of how care is delivered in the real world."
Green emphasized the company's position in the transforming $60 billion real-world evidence industry, stating that OneMedNet is "at the forefront, helping make evidence generation faster, more effective, and more grounded in real clinical reality."
Revenue Growth Trajectory
The exponential network growth positions OneMedNet for significant revenue generation through increased data licensing and new enterprise partnerships. The company's enhanced operational capacity and expanded reach create a foundation for accelerated customer acquisition and data monetization at scale.
Technology Platform
OneMedNet's iRWD™ platform harnesses data from over 1,750 healthcare sites, spanning specialties including rare diseases, oncology, and cardiology. The platform processes de-identified medical imaging and electronic health records to fuel breakthroughs for drugmakers, medical device companies, and AI developers.
Beyond healthcare applications, OneMedNet's proprietary AI technology anonymizes data for industries including finance, retail, and telecommunications, enabling secure data sharing by removing personal information while maintaining analytical value for system testing and complex project risk mitigation.
